Selinexor in relapsed/refractory multiple myeloma

por Richter, Joshua, Madduri, Deepu, Richard, Shambavi, Chari, Ajai
Publicado 2020

B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies

por Sanchez, Larysa, Dardac, Alexandra, Madduri, Deepu, Richard, Shambavi, Richter, Joshua
Publicado 2021

MM-239: A Tertiary Center Experience of Multiple Myeloma Patients with COVID-19: Lessons Learned and the Path Forward

por Wang, Bo, Oekelen, Oliver Van, Mouhieddine, Tarek, Jagannath, Sundar, Parekh, Samir, Madduri, Deepu
Publicado 2020

Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies

por Lancman, Guido, Arinsburg, Suzanne, Jhang, Jeffrey, Cho, Hearn Jay, Jagannath, Sundar, Madduri, Deepu, Parekh, Samir, Richter, Joshua, Chari, Ajai
Publicado 2018

Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma

por Sanchez, Larysa, Richter, Joshua, Cho, Hearn Jay, Jagannath, Sundar, Madduri, Deepu, Parekh, Samir, Richard, Shambavi, Tam, Lowena, Verina, Daniel, Chari, Ajai
Publicado 2021

A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward

por Wang, Bo, Van Oekelen, Oliver, Mouhieddine, Tarek H., Del Valle, Diane Marie, Richter, Joshua, Cho, Hearn Jay, Richard, Shambavi, Chari, Ajai, Gnjatic, Sacha, Merad, Miriam, Jagannath, Sundar, Parekh, Samir, Madduri, Deepu
Publicado 2020

A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward

por Wang, Bo, Van Oekelen, Oliver, Mouhieddine, Tarek H., Del Valle, Diane Marie, Richter, Joshua, Cho, Hearn Jay, Richard, Shambavi, Chari, Ajai, Gnjatic, Sacha, Merad, Miriam, Jagannath, Sundar, Parekh, Samir, Madduri, Deepu
Publicado 2020

Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications

por Bhalla, Sherry, Melnekoff, David T., Aleman, Adolfo, Leshchenko, Violetta, Restrepo, Paula, Keats, Jonathan, Onel, Kenan, Sawyer, Jeffrey R., Madduri, Deepu, Richter, Joshua, Richard, Shambavi, Chari, Ajai, Cho, Hearn Jay, Dudley, Joel T., Jagannath, Sundar, Laganà, Alessandro, Parekh, Samir
Publicado 2021

Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach

por Laganà, Alessandro, Beno, Itai, Melnekoff, David, Leshchenko, Violetta, Madduri, Deepu, Ramdas, Dennis, Sanchez, Larysa, Niglio, Scot, Perumal, Deepak, Kidd, Brian A., Miotto, Riccardo, Houldsworth, Jane, Shaknovich, Rita, Chari, Ajai, Cho, Hearn Jay, Barlogie, Bart, Jagannath, Sundar, Dudley, Joel T., Parekh, Samir
Publicado 2018

Phase 1b trial of isatuximab, an anti‐CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma

por Martin, Thomas G., Shah, Nina, Richter, Joshua, Vesole, David H., Wong, Sandy W., Huang, Chiung‐Yu, Madduri, Deepu, Jagannath, Sundar, Siegel, David S., Biran, Noa, Wolf, Jeffrey L., Parekh, Samir, Cho, Hearn J., Munster, Pamela, Richard, Shambavi, Ziti‐Ljajic, Samira, Chari, Ajai
Publicado 2021

S202: CARTITUDE-1 FINAL RESULTS: PHASE 1B/2 STUDY OF CILTACABTAGENE AUTOLEUCEL IN HEAVILY PRETREATED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

por Munshi, Nikhil, Martin, Tom, Usmani, Saad Z, Berdeja, Jesus, Jakubowiak, Andrzej, Agha, Mounzer, Cohen, Adam D, Deol, Abhinav, Htut, Myo, Lesokhin, Alexander, Lin, Yi, O’donnell, Elizabeth, Jackson, Carolyn C, Yeh, Tzu-Min, Banerjee, Arnob, Zudaire, Enrique, Madduri, Deepu, Delcorral, Christopher, Pacaud, Lida, Jagannath, Sundar
Publicado 2023

Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial

por Lin, Yi, Raje, Noopur S., Berdeja, Jesús G., Siegel, David S., Jagannath, Sundar, Madduri, Deepu, Liedtke, Michaela, Rosenblatt, Jacalyn, Maus, Marcela V., Massaro, Monica, Petrocca, Fabio, Yeri, Ashish, Finney, Olivia, Caia, Andrea, Yang, Zhihong, Martin, Nathan, Campbell, Timothy B., Rytlewski, Julie, Fuller, Jaymes, Hege, Kristen, Munshi, Nikhil C., Kochenderfer, James N.
Publicado 2023

COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers

por Hultcrantz, Malin, Richter, Joshua, Rosenbaum, Cara, Patel, Dhwani, Smith, Eric, Korde, Neha, Lu, Sydney, Mailankody, Sham, Shah, Urvi, Lesokhin, Alexander, Hassoun, Hani, Tan, Carlyn, Maura, Francesco, Derkacs, Andriy, Diamond, Benjamin, Rossi, Adriana, Pearse, Roger N., Madduri, Deepu, Chari, Ajai, Kaminetsky, David, Braunstein, Marc, Gordillo, Christian, Davies, Faith, Jagannath, Sundar, Niesvizky, Ruben, Lentzsch, Suzanne, Morgan, Gareth, Landgren, Ola
Publicado 2020

Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial

por Criner, Gerard J., Lang, Frederick M., Gottlieb, Robert L., Mathews, Kusum S., Wang, Tisha S., Rice, Todd W., Madduri, Deepu, Bellam, Shashi, Jeanfreau, Robert, Case, Amy H., Glassberg, Marilyn K., Lyon, George Marshall, Ahmad, Kareem, Mendelson, Robert, DiMaio, J. Michael, Tran, MaryAnn P., Spak, Cedric W., Abbasi, Jamil A., Davis, Steven G., Ghamande, Shekhar, Shen, Steven, Sherman, Lisa, Lowry, Simon
Publicado 2022

BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma

por Raghunandan, Sharmila, Pauly, Melinda, Blum, William G, Qayed, Muna, Dhodapkar, Madhav V, Elkhalifa, Mohamed, Watkins, Benjamin, Schoettler, Michelle, Horwitz, Edwin, Parikh, Suhag, Chandrakasan, Shanmuganathan, Leung, Kathryn, Bryson, Elyse, Deeb, Laura, Kaufman, Jonathan L, Worthington-White, Diana, Alazraki, Adina, Schecter, Jordan M, Madduri, Deepu, Jackson, Carolyn C, Zudaire, Enrique, Taraseviciute-Morris, Agne, Babich, Alexander, Nesheiwat, Tonia, Vogel, Martin, Lendvai, Nikoletta, Pacaud, Lida, Williams, Kirsten M
Publicado 2023

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

por Cohen, Adam D., Parekh, Samir, Santomasso, Bianca D., Gállego Pérez-Larraya, Jaime, van de Donk, Niels W. C. J., Arnulf, Bertrand, Mateos, Maria-Victoria, Lendvai, Nikoletta, Jackson, Carolyn C., De Braganca, Kevin C., Schecter, Jordan M., Marquez, Loreta, Lee, Erin, Cornax, Ingrid, Zudaire, Enrique, Li, Claire, Olyslager, Yunsi, Madduri, Deepu, Varsos, Helen, Pacaud, Lida, Akram, Muhammad, Geng, Dong, Jakubowiak, Andrzej, Einsele, Hermann, Jagannath, Sundar
Publicado 2022

Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up

por Martin, Thomas, Usmani, Saad Z., Berdeja, Jesus G., Agha, Mounzer, Cohen, Adam D., Hari, Parameswaran, Avigan, David, Deol, Abhinav, Htut, Myo, Lesokhin, Alexander, Munshi, Nikhil C., O'Donnell, Elizabeth, Stewart, A. Keith, Schecter, Jordan M., Goldberg, Jenna D., Jackson, Carolyn C., Yeh, Tzu-Min, Banerjee, Arnob, Allred, Alicia, Zudaire, Enrique, Deraedt, William, Olyslager, Yunsi, Zhou, Changwei, Pacaud, Lida, Madduri, Deepu, Jakubowiak, Andrzej, Lin, Yi, Jagannath, Sundar
Publicado 2023

COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers

por Hultcrantz, Malin, Richter, Joshua, Rosenbaum, Cara A., Patel, Dhwani, Smith, Eric L., Korde, Neha, Lu, Sydney X., Mailankody, Sham, Shah, Urvi A., Lesokhin, Alexander M., Hassoun, Hani, Tan, Carlyn, Maura, Francesco, Derkach, Andriy, Diamond, Benjamin, Rossi, Adriana, Pearse, Roger N., Madduri, Deepu, Chari, Ajai, Kaminetzky, David, Braunstein, Marc J., Gordillo, Christian, Reshef, Ran, Taur, Ying, Davies, Faith E., Jagannath, Sundar, Niesvizky, Ruben, Lentzsch, Suzanne, Morgan, Gareth J., Landgren, Ola
Publicado 2020